Related Experiment Video
Updated: Apr 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites
Juan Carlos Bazo-Alvarez1, Renato Quispe, Frank Peralta
1From the *CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; †Santa Cruz de Ratacocha Primary Healthcare Centre, Social Service in Rural Setting, Ministry of Health, Huanuco, Peru; ‡Division of Cardiology, Department of Medicine, §Duke Clinical Research Institute, ¶Duke Global Health Institute, Duke University, Durham, NC; ‖School of Medicine, University College London, London, UK; **Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ††Asociación Benéfica PRISMA, Lima, Peru; ‡‡Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD; §§Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; and ¶¶Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Insights
Cardiovascular disease (CVD) risk scores show poor agreement in Peruvian populations. Current tools lack reliability for public health interventions in low- and middle-income countries, necessitating improved risk assessment strategies.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Cardiovascular disease (CVD) risk prediction accuracy in low- and middle-income countries (LMICs) is uncertain.
- Existing CVD risk scores may not be suitable for diverse global populations.
Purpose of the Study:
- To compare the performance of the American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort risk equations against six other CVD risk tools.
- To assess the concordance of predicted CVD risk using various tools in Peruvian populations.
Main Methods:
- Utilized data from two Peruvian population-based studies across five geographical sites.
- Compared the ACC/AHA model with Framingham (lab and non-lab), Reynolds, Systematic Coronary Risk Evaluation, WHO, and Lancet risk charts.
- Employed Lin's concordance correlation coefficient to measure agreement in predicted CVD risk.
Main Results:
- Analyzed data from 2,183 subjects (mean age 54.3 years).
- Found poor agreement between the ACC/AHA model and other compared CVD risk scores.
- The ACC/AHA model identified a higher proportion of individuals at high 10-year CVD risk (29.0%) compared to WHO risk charts (0.6%).
Conclusions:
- The poor concordance among CVD risk scores highlights uncertainty in their application for public health and clinical decisions in Latin America.
- There is a critical need for developing and validating CVD risk scores specifically for LMICs.
- Current risk assessment tools require improvement to accurately predict CVD risk in diverse, underrepresented populations.
Abstract:
It is unclear how well currently available risk scores predict cardiovascular disease (CVD) risk in low-income and middle-income countries. We aim to compare the American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort risk equations (ACC/AHA model) with 6 other CVD risk tools to assess the concordance of predicted CVD risk in a random sample from 5 geographically diverse Peruvian populations. We used data from 2 Peruvian, age and sex-matched, population-based studies across 5 geographical sites. The ACC/AHA model were compared with 6 other CVD risk prediction tools: laboratory Framingham risk score for CVD, non-laboratory Framingham risk score for CVD, Reynolds risk score, systematic coronary risk evaluation, World Health Organization risk charts, and the Lancet chronic diseases risk charts. Main outcome was in agreement with predicted CVD risk using Lin's concordance correlation coefficient. Two thousand one hundred and eighty-three subjects, mean age 54.3 (SD ± 5.6) years, were included in the analysis. Overall, we found poor agreement between different scores when compared with ACC/AHA model. When each of the risk scores was used with cut-offs specified in guidelines, ACC/AHA model depicted the highest proportion of people at high CVD risk predicted at 10 years, with a prevalence of 29.0% (95% confidence interval, 26.9-31.0%), whereas prevalence with World Health Organization risk charts was 0.6% (95% confidence interval, 0.2-8.6%). In conclusion, poor concordance between current CVD risk scores demonstrates the uncertainty of choosing any of them for public health and clinical interventions in Latin American populations. There is a need to improve the evidence base of risk scores for CVD in low-income and middle-income countries.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Relative Risk
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease IV: Preventive Measures